Filtered By:
Specialty: Endocrinology
Condition: Diabetes

This page shows you your search results in order of relevance. This is page number 17.

Order by Relevance | Date

Total 1416 results found since Jan 2013.

Risk of early mortality and cardiovascular disease according to the presence of recently ‐diagnosed diabetes and requirement for insulin treatment: a nationwide study
ConclusionsRecently ‐diagnosed T2D patients showed increased risks of incident CVDs and premature mortality, and insulin‐treated group demonstrated an additional increase in the risks of these outcomes in adults with recently‐diagnosed T2D, suggesting the need for intensified cardio‐protective interventions for adults with insulin‐treated T2D.
Source: Journal of Diabetes Investigation - March 4, 2021 Category: Endocrinology Authors: You ‐Bin Lee, Kyungdo Han, Bongsung Kim, Min Sun Choi, Jiyun Park, Minyoung Kim, Sang‐Man Jin, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim Tags: ORIGINAL ARTICLE Source Type: research

Incidence of adverse cardiovascular events in type  2 diabetes mellitus patients after initiation of glucose‐lowering agents: A population‐based community study from the Shizuoka Kokuho database
ConclusionsThe incidence of HHF was similar to that of stroke. A significant portion of our cohort met the inclusion criteria for major randomized clinical trials for SGLT2i, and estimated reduction in the HHF events was substantial.
Source: Journal of Diabetes Investigation - January 29, 2021 Category: Endocrinology Authors: Shun Kohsaka, Hiraku Kumamaru, Shiori Nishimura, Satoshi Shoji, Eiji Nakatani, Nao Ichihara, Hiroyuki Yamamoto, Yoshiki Miyachi, Hiroaki Miyata Tags: Original Article Source Type: research

Impact of vision and hearing impairments on risk of cardiovascular outcomes and mortality in patients with type 2 diabetes: a nationwide cohort study
ConclusionsVision and hearing impairments are independently important risk factors for adverse cardiovascular events and mortality in patients with type 2 diabetes. Vision and hearing impairments synergistically increased the risk of MI and all-cause deaths, but not stroke. In addition, in under 65 years of age, the HR of vision impairment was higher than those with vision and hearing impairments.
Source: Journal of Diabetes Investigation - October 8, 2021 Category: Endocrinology Authors: Younhea Jung, Kyungdo Han, Ji Min Lee, Hye Yeon Park, Jung Il Moon Tags: ORIGINAL ARTICLE Source Type: research

Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials
Conclusions/interpretationAdherence to Nordic dietary patterns is associated with generally small important reductions in the risk of major CVD outcomes and diabetes, which are supported by similar reductions in LDL-cholesterol and other intermediate cardiometabolic risk factors. The available evidence provides a generally good indication of the likely benefits of Nordic dietary patterns in people with or at risk for diabetes.RegistrationClinicalTrials.gov NCT04094194.FundingDiabetes and Nutrition Study Group of the EASD Clinical Practice.Graphical abstract
Source: Diabetologia - August 26, 2022 Category: Endocrinology Source Type: research

Effects of GLP-1 receptor agonists on neurological complications of diabetes
Rev Endocr Metab Disord. 2023 May 26. doi: 10.1007/s11154-023-09807-3. Online ahead of print.ABSTRACTEmerging evidence suggests that treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) could be an interesting treatment strategy to reduce neurological complications such as stroke, cognitive impairment, and peripheral neuropathy. We performed a systematic review to examine the evidence concerning the effects of GLP-1 RAs on neurological complications of diabetes. The databases used were Pubmed, Scopus and Cochrane. We selected clinical trials which analysed the effect of GLP-1 RAs on stroke, cognitive impair...
Source: ENDOCR REV - May 25, 2023 Category: Endocrinology Authors: Natalia Garc ía-Casares Guillermo Gonz ález-González Carlos de la Cruz-Cosme Francisco J Garz ón-Maldonado Carmen de Rojas-Leal Mar ía J Ariza Manuel Narv áez Miguel Ángel Barbancho Juan Antonio Garc ía-Arnés Francisco J Tinahones Source Type: research

Primary hyperaldosteronism is associated with increased mortality and morbidity in patients with hypertension and diabetes
ConclusionPrimary hyperaldosteronism in patients with hypertension and diabetes is associated with increased mortality and morbidity.
Source: Frontiers in Endocrinology - May 26, 2023 Category: Endocrinology Source Type: research

Effects of GLP-1 receptor agonists on neurological complications of diabetes
AbstractEmerging evidence suggests that treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) could be an interesting treatment strategy to reduce neurological complications such as stroke, cognitive impairment, and peripheral neuropathy. We performed a systematic review to examine the evidence concerning the effects of GLP-1 RAs on neurological complications of diabetes. The databases used were Pubmed, Scopus and Cochrane. We selected clinical trials which analysed the effect of GLP-1 RAs on stroke, cognitive impairment, and peripheral neuropathy. We found a total of 19 studies: 8 studies include stroke or ...
Source: Reviews in Endocrine and Metabolic Disorders - May 26, 2023 Category: Endocrinology Source Type: research

Atherosclerotic Cardiovascular Disease in Type  2 Diabetes: A Retrospective, Observational Study of Economic and Clinical Burden in Sweden
ConclusionsASCVD is associated with considerable costs, morbidity and mortality in individuals with T2D. These results support structured assessment of ASCVD risk and broader implementation of guideline-recommended treatments in T2D healthcare.
Source: Diabetes Therapy - June 16, 2023 Category: Endocrinology Source Type: research